Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FGYA9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,883
Award facts
- Contract value 100% obligated
- $11,882.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on October 28, 2025, for $11,882.88 in BOTOX 200-unit vials. This firm fixed-price delivery order, with an ultimate completion date of November 19, 2025, was issued without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The award supports the Department of Defense's pharmaceutical supply needs and represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion enterprise-wide acquisition strategy. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a $499,999,999 ceiling value through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V framework positions DMS Pharmaceutical Group as a regional prime vendor authorized to supply a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FGYA9?
SPE2DR26FGYA9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FGYA9 worth?
The government has obligated $11,883 on SPE2DR26FGYA9.
Is contract SPE2DR26FGYA9 an order under another contract?
Yes. SPE2DR26FGYA9 is a delivery order under SPE2DR25D9637, an indefinite delivery contract.
Was contract SPE2DR26FGYA9 competed?
The extent of competition for SPE2DR26FGYA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award